Estrogen Receptor Silencing Leads to Epithelial to Mesenchymal Transition in Breast Cancer Cells
Author Information
Author(s): Al Saleh Sanaa, Al Mulla Fahd, Luqmani Yunus A.
Primary Institution: Kuwait University
Hypothesis
Loss of estrogen receptor function leads to trans-differentiation from an epithelial to a mesenchymal phenotype responsible for increased aggressiveness and metastatic propensity.
Conclusion
The study shows that silencing the estrogen receptor in breast cancer cells triggers a series of changes that lead to a more aggressive and metastatic cell type.
Supporting Evidence
- Silencing the estrogen receptor resulted in altered cell morphology and increased motility.
- Phenotypic profiling indicated significant changes in gene expression associated with cell motility and loss of adhesion.
- Cells exhibited a switch from epithelial to mesenchymal markers, indicating a transition towards a more aggressive phenotype.
Takeaway
When breast cancer cells lose their estrogen receptor, they change into a more aggressive form that can spread more easily in the body.
Methodology
The study involved silencing the estrogen receptor in MCF7 breast cancer cells and analyzing changes in morphology, motility, and gene expression.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website